ROLTISA 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG

Pharmathen S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: fe98521911085110
Drug Cima Aemps Name: ROLTISA 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG
Register Number: 88194
Holder Company Name: Pharmathen S.A.
Marketing Company Name: Pharmathen S.A.
Holder Company Detail Path: /organization/pharmathen-s-a
Marketing Company Detail Path: /organization/pharmathen-s-a
Authorization Date: 2022-10-14
Dosage Form: CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Dose: 0,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Pharmathen S.A.
Company Detail Path: /organization/pharmathen-s-a

TACROLIMUS MONOHIDRATO

0,511 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 14, 2022

Approval ID

fe98521911085110

Type

Standard